Veradermics, Incorporated (MANE)

Veradermics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.01	0.05	0.02
Cash & Cash Equivalents	0.02	0.05	0.02
Cash Growth	-	225.75%	-
Other Current Assets	0	0	0
Total Current Assets	0.02	0.06	0.02
Total Assets	-	0.06	0.02
Accounts Payable	-	0	0
Other Current Liabilities	0.01	0	0
Total Current Liabilities	0.01	0	0
Long-Term Debt	-	-	0
Total Long-Term Liabilities	-	0	0
Total Liabilities	-	0	0
Total Debt	0	0	0
Retained Earnings	-	-0.05	-0.02
Shareholders' Equity	-0.1	-0.05	-0.02
Net Cash (Debt)	0.01	0.05	0.02
Net Cash (Debt) Growth	-	242.26%	-
Working Capital	0.01	0.05	0.01

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).